Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05709483 · ClinicalTrials.gov registry record · Early Phase 1
Predictors of Aspirin Failure in Preeclampsia Prevention
A Early Phase 1 study of Preeclampsia, sponsored by Rockefeller University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 130
- Enrollment target
- 1
- Study location
NCT05709483 is a Early Phase 1 study of Preeclampsia that is actively recruiting participants, run by Rockefeller University. The registered enrollment target is 130 participants, below the 1,279-participant average among 39 other Preeclampsia trials with a reported enrollment target (90% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05709483, a Early Phase 1 study of Preeclampsia, is actively recruiting participants, sponsored by Rockefeller University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 130 participants
- Enrollment target
- 1
- Study location
Study Summary
Hypertensive disorders of pregnancy (including preeclampsia) are among the leading causes of pregnancy complications and maternal deaths worldwide. They also increase the risks to the babies. Numerous interventions have been suggested in order to reduce the rate of preeclampsia. Low-dose aspirin is the most beneficial prophylactic approach in this regard. Nevertheless, aspirin failure is not uncommon. The genetic, laboratory, and clinical factors associated with low-dose aspirin failure in the prevention of preeclampsia are largely unknown. The presence of a genetic variant in PAR4 receptor expressed on platelets, is associated with increased platelet function and possibly with aspirin failure.
Conditions Studied
Interventions
- DRUG Aspirin
Study Locations (1)
New York
- Rockefeller University - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 130 participants |
| Start Date | 2023-04-13 |
| Est. Completion | 2026-11-01 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05709483
The ClinicalTrials.gov registry entry for NCT05709483 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 130 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,279-participant average among 39 other Preeclampsia trials with a reported enrollment target (90% lower). The listed sponsor is Rockefeller University, which has 117 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Preeclampsia appearing as the primary indexed condition, and to 1 intervention - of which Aspirin is the first listed.
NCT05709483 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05709483 about?
NCT05709483 is a clinical study titled "Predictors of Aspirin Failure in Preeclampsia Prevention". Hypertensive disorders of pregnancy (including preeclampsia) are among the leading causes of pregnancy complications and maternal deaths worldwide. They also increase the risks to the babies. Numerous interventions have been suggested in order to reduce the rate of preeclampsia. Low-dose aspirin is ...
What is the current status of trial NCT05709483?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 130 participants. The study started on 2023-04-13. Estimated completion is 2026-11-01.
What conditions does trial NCT05709483 study?
This clinical trial studies the following conditions: Preeclampsia.
What interventions are being tested in trial NCT05709483?
The interventions under investigation include: Aspirin (DRUG).
Who is sponsoring clinical trial NCT05709483?
This trial is sponsored by Rockefeller University, which has 117 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05709483 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Preeclampsia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Daily Aspirin Treatment After Preeclampsia
RECRUITING · Early Phase 1
-
Prenatal Aspirin and Postpartum Vascular Function
RECRUITING · Early Phase 1
-
Vascular Effects of High-Salt After Preeclampsia
RECRUITING · Early Phase 1
-
MR and Inflammation After Preeclampsia
ACTIVE NOT RECRUITING · Early Phase 1
-
Postpartum Hemorrhage Prevention in Patients With Preeclampsia (PHP3 Study)
COMPLETED · Early Phase 1
-
Spironolactone to Improve Pregnancy-Associated Hypertension Trajectories
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.